Atlas Trials

Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors

Clinical trial NCT06948955 · AVAILABLE

Trial details

NCT number
NCT06948955
Sponsor
Cogent Biosciences, Inc.
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.